N. Masuda

发表

ITERATIVE EXTENSION OF THIOPHENE RING LEADING TO HEAD-TO-TAIL-TYPE OLIGOTHIOPHENES VIA STEPWISE CH ARYLATION AND HALOGEN EXCHANGE SEQUENCE

K. Hara, N. Koumura, A. Mori, 2010 .

Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines.

M. Takeuchi, Y. Matsumoto, M. Ohta, 2009, Bioorganic & medicinal chemistry.

Binding Modes of Two Novel Non-Nucleoside Reverse Transcriptase Inhibitors, YM-215389 and YM-228855, to HIV Type-1 Reverse Transcriptase

M. Matsuoka, H. Inoue, E. Kodama, 2008, Antiviral Chemistry & Chemotherapy.

Dinuclear Copper(II) 3,4,5-Tri-O-benzylgallate

M. Handa, Hidekazu Tanaka, M. Mikuriya, 2018, Open Chemistry Journal.

Synthesis, crystal structures, spectral, electrochemical and magnetic properties of di-µ-phenoxido-bridged dinuclear copper(II) complexes with N-salicylidene-2-hydroxybenzylamine derivatives: axial coordination effect of dimethyl sulphoxide molecule

T. Hashimoto, M. Handa, H. Sakiyama, 2014, Chemical Papers.

Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives.

M. Matsuoka, M. Baba, H. Inoue, 2005, Bioorganic & medicinal chemistry.

Mononuclear cobalt (III) complexes with N-salicylidene-2-hydroxy-5-bromobenzylamine and N-salicylidene-2-hydroxy-5-chlorobenzylamine

M. Mikuriya, D. Yoshioka, Shinya Minato, 2016, Chemical Papers.

Regioselective Alkylation of Thiazolylsulfonamides: Direct and Efficient Synthesis of 3‐Alkylthiazolidene Derivatives

T. Kontani, Ayako Moritomo, M. Ohta, 2005 .

Synthesis and Crystal Structure of N -Salicylidene-2-hydroxy-5-bromobenzylamine

M. Mikuriya, D. Yoshioka, N. Masuda, 2008 .

Fragment-Based Discovery of Pyrimido[1,2-b]indazole PDE10A Inhibitors.

T. Mihara, Y. Amano, I. Namatame, 2018, Chemical & pharmaceutical bulletin.

Novel benzimidazole derivatives as phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability.

T. Mihara, Y. Amano, M. Yamazaki, 2014, Bioorganic & medicinal chemistry.

Design and synthesis of novel benzimidazole derivatives as phosphodiesterase 10A inhibitors with reduced CYP1A2 inhibition.

S. Kikuchi, Toshihiro Watanabe, T. Mihara, 2013, Bioorganic & medicinal chemistry.

Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides.

M. Matsuoka, M. Baba, H. Inoue, 2004, Bioorganic & medicinal chemistry.

Addressing phototoxicity observed in a novel series of biaryl derivatives: discovery of potent, selective and orally active phosphodiesterase 10A inhibitor ASP9436.

S. Kikuchi, T. Mihara, K. Hattori, 2015, Bioorganic & medicinal chemistry.

The first total synthesis of natural (+)-terpestacin, syncytium formation inhibitor.

K. Tatsuta, N. Masuda, 1998, The Journal of antibiotics.

The First Total Synthesis of (±)-Terpestacin, HIV Syncytium Formation Inhibitor

K. Tatsuta, N. Masuda, H. Nishida, 1998 .

Synthesis, SAR study, and biological evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors with reduced CYP3A4 inhibition.

S. Kikuchi, T. Mihara, K. Hattori, 2015, Bioorganic & medicinal chemistry.

Stepwise construction of head-to-tail-type oligothiophenes via iterative palladium-catalyzed CH arylation and halogen exchange.

K. Hara, N. Koumura, A. Mori, 2009, Organic letters.

Potent CCR4 antagonists: synthesis, evaluation, and docking study of 2,4-diaminoquinazolines.

M. Orita, M. Takeuchi, Y. Matsumoto, 2008, Bioorganic & medicinal chemistry.

Synthesis and in vivo evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors.

Toshihiro Watanabe, T. Mihara, Kaori Takama, 2014, Chemical and pharmaceutical bulletin.

Synthesis, SAR study, and biological evaluation of novel 2,3-dihydro-1H-imidazo[1,2-a]benzimidazole derivatives as phosphodiesterase 10A inhibitors.

Y. Amano, Koichi Yonezawa, M. Yamazaki, 2019, Bioorganic & medicinal chemistry.